Insilico discovery of novel Phosphodiesterase 4 (PDE4) inhibitors for the treatment of psoriasis: Insights from computer aided drug design approaches.

Psoriasis is chronic immune-mediated inflammatory disorder characterized by various comorbidities, erythematous plaques with silvery scale which can lead to psoriatic arthritis. The phosphodiesterase 4 (PDE4) protein is a potential drug target to control Psoriasis. In the current study, pharmacophor...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdullah R Alanzi, Mohammed S Alsalhi, Ramzi A Mothana, Jawaher H Alqahtani, Moneerah J Alqahtani
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0305934
Tags: Add Tag
No Tags, Be the first to tag this record!